Only logged in customers who have purchased this product may leave a review.
Cagrilintide 10mg
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 10mg
R1199,00
Availability: In stock
SKU: CGL10
Cagrilintide 10mg
R1199,00
Cagrilintide is a long-acting amylin analogue currently being investigated for appetite regulation, body weight management and metabolic health. Designed for once-weekly administration, it has demonstrated significant weight reduction in clinical trials.
Availability: In stock
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About Cagrilintide 10mg
Cagrilintide is a synthetic, long-acting analogue of the pancreatic hormone amylin. Amylin is co-secreted with insulin after meals and contributes to appetite regulation, gastric emptying and satiety. Lipid modification extends its half-life, allowing convenient once-weekly dosing. It is being studied both alone and in combination with GLP-1 receptor agonists such as semaglutide (CagriSema).
How It Works in Research
Cagrilintide is an acylated analogue of amylin, a hormone released with insulin from pancreatic beta cells. It activates central amylin receptors involved in appetite regulation, promoting satiety and reducing food intake. It also slows gastric emptying, prolonging fullness after meals. Unlike GLP-1 agonists it acts through the amylin pathway, making it complementary to GLP-1 receptor agonists. Its long half-life supports once-weekly administration.
Research Applications
• Weight management • Appetite suppression • Obesity research • Gastric emptying • Glucose regulation • Combination therapy
Cagrilintide mimics the body's natural amylin hormone, helping the brain recognize fullness while slowing stomach emptying so meals satisfy for longer.
Product Specifications
- Product Name: Cagrilintide
- Alternate Chemical Name: Long-acting Amylin Analogue
- Reference Strength: 10 mg
- Appearance: White to off-white lyophilised powder
Research Information
- Purity Standard: ≥98% (HPLC)
- Category: Amylin Receptor Agonist
- Storage: 2–8°C after reconstitution
Mechanism of Action
Cagrilintide is an acylated analogue of amylin, a hormone released with insulin from pancreatic beta cells. It activates central amylin receptors involved in appetite regulation, promoting satiety and reducing food intake. It also slows gastric emptying, prolonging fullness after meals. Unlike GLP-1 agonists it acts through the amylin pathway, making it complementary to GLP-1 receptor agonists. Its long half-life supports once-weekly administration.
Key Research Characteristics
Long-acting acylated amylin analogue
Once-weekly administration Appetite regulation research Weight management research Metabolic health Combination therapy studies
Potential Benefits in Research
Clinical studies have demonstrated dose-dependent weight reduction, improved satiety, reduced caloric intake, convenient once-weekly dosing and enhanced weight-loss outcomes when combined with semaglutide.
Safety Profile
Most reported adverse effects are gastrointestinal, including nausea, vomiting, diarrhoea and constipation. Mild injection-site reactions may occur. Gradual dose escalation generally improves tolerability.
Research Applications
Weight management
Appetite suppression
Obesity research
Gastric emptying
Glucose regulation
Combination therapy
REFERENCE RECONSTITUTION INFORMATION
Goal: Support appetite regulation, satiety and weight management. Schedule: Once-weekly subcutaneous administration. Dose Range: 0.6–4.5 mg weekly. Reconstitution: Add 3.0 mL bacteriostatic water to one 10 mg vial (3.33 mg/mL).
Always follow sterile preparation techniques when handling research peptides.
⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only.
General Preparation
• Use a new sterile syringe for each injection. • Rotate injection sites. • Administer on the same day each week. • Maintenance doses above 1.0 mL require a larger syringe than a standard 1 mL insulin syringe.
- Add 3.0 mL bacteriostatic water slowly down the vial wall. Swirl gently until dissolved. Do not shake. Refrigerate immediately after reconstitution.
CAGRILINTIDE (10MG)- RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of Cagrilintide 10mg.
- Schedule: Once-weekly subcutaneous administration.
- Dose Range: 0.6–4.5 mg weekly.
Reference Parameters (Dosing & Reconstitution Guide)
| Week | Weekly Dose | U-100 Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.6 mg | 18 | 0.18 mL |
| Weeks 3–4 | 1.2 mg | 36 | 0.36 mL |
| Weeks 5–6 | 2.4 mg | 72 | 0.72 mL |
| Weeks 7+ | 4.5 mg | 135 | 1.35 mL |
For laboratory research only.
Experimental Study Period
RESEARCH CONTEXT
Support appetite regulation, satiety and weight management.
Once-weekly subcutaneous administration.
View Certificate of Analysis
View Certificate of Analysis Each batch of Cagrilintide is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
99.6%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Related products
-
Metabolic Research
MOTS-c
Price range: R639,00 through R1199,00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.
Reviews
There are no reviews yet.